Marijuana is a banned substance by the National Football League while opioids are the typical pain management prescription. Harvard Medical School recently hosted a cannabis conference where NFL athletes spoke about why this could change.
Some people love a challenge. If you want to combine the arduous labor of growing a complex plant like cannabis with the intensity of aquaponics (cultivation of plants in water with fish), you have taken on a double whammy challenge with a big potential payout.
While the US cannabis economy struggles with a fragmented legal framework Canada pursues a very different model.
BIG IDEA: Products for the legal marijuana industry. First up will be LightLab, a “portable, lab-grade cannabis potency analyzer” that the company says will give growers, dispensaries, regulators, and manufacturers of marijuana-infused products a fast, reliable, and affordable way to maintain quality control. Instead of waiting several days for a lab to perform potency tests, they could get results in less than ten minutes.
The AOCS annual meeting brought leaders in analytical chemistry to discuss the changing cannabis safety landscape...Dylan Wilks, chief scientific officer at Orange Photonics, discussed the various needs in sample preparation for a wide range of products. He focused on sample prep and variation for on-site potency analysis, which could give edibles manufacturers crucial quality assurance tools in process control. Susan Audino, Ph.D., chemist and A2LA assessor, echoed Wilks’ concerns over sample collection methods.
Startups dealing with marijuana could be positioned to see serious green. Forbes stated that a recent report revealed that legal cannabis sales in the U.S. grew 184 percent last year. For 2015, our country’s legitimate marijuana business was worth $5.4 billion and much of the growth was due to a rise in recreational sales, which went from $351 million in 2014 to $998 million in 2015.